ACTA1 and cancer: Using multiple anti‐αSMA antibodies, including the previously reported antibodies in PDAC GEMMs (Aiello et al, 2016), αSMA‐expressing cancer cells with an EMT program could also be detected in the primary tumors (Appendix Figs S2 and S3).